bibtype J - Journal Article
ARLID 0565799
utime 20240103231038.2
mtime 20221221235959.9
SCOPUS 85138447693
WOS 000824848900001
DOI 10.1093/infdis/jiac259
title (primary) (eng) Response to Beran et al
specification
page_count 2 s.
media_type P
serial
ARLID cav_un_epca*0253827
ISSN 0022-1899
title Journal of Infectious Diseases
volume_id 226
volume 5 (2022)
page_num 944-945
publisher
name Oxford University Press
keyword vaccination
keyword booster dose effectiveness
keyword Letter to the Editor
author (primary)
ARLID cav_un_auth*0101206
name1 Šmíd
name2 Martin
institution UTIA-B
full_dept (cz) Ekonometrie
full_dept (eng) Department of Econometrics
department (cz) E
department (eng) E
garant K
fullinstit Ústav teorie informace a automatizace AV ČR, v. v. i.
author
ARLID cav_un_auth*0270143
name1 Berec
name2 L.
country CZ
author
ARLID cav_un_auth*0091778
name1 Trnka
name2 J.
country CZ
source
url http://library.utia.cas.cz/separaty/2022/E/smid-0565799.pdf
cas_special
abstract (eng) We read the letter by Beran et al [1] and welcome the opportunity to address all the points raised. The authors consider our article [2] to be “promoting the need of vaccination and inflating the booster dose effectiveness,” and they support this claim by several arguments questioning our methods. Our view, however, is that our methods are standard, previously used [3], and certainly not tailor made for vaccination and all their details are clearly described.
result_subspec WOS
RIV BC
FORD0 10000
FORD1 10100
FORD2 10102
reportyear 2023
num_of_auth 3
inst_support RVO:67985556
permalink https://hdl.handle.net/11104/0337919
confidential S
mrcbC91 C
mrcbT16-e IMMUNOLOGY|INFECTIOUSDISEASES|MICROBIOLOGY
mrcbT16-j 2.208
mrcbT16-s 2.386
mrcbT16-D Q1
mrcbT16-E Q1*
arlyear 2022
mrcbU14 85138447693 SCOPUS
mrcbU24 PUBMED
mrcbU34 000824848900001 WOS
mrcbU63 cav_un_epca*0253827 Journal of Infectious Diseases 0022-1899 1537-6613 Roč. 226 č. 5 2022 944 945 Oxford University Press